Don’t wait for disruption to impact your critical life sciences supply chain.
In a highly regulated sector like life sciences, defined by complex, multi-tiered supply chains that demand efficiency and reliability, extensive outsourcing can amplify supply chain risks. Precision is paramount when transporting critical drugs, yet reduced oversight and visibility over manufacturing processes and supplier networks can complicate quality control, traceability, and regulatory compliance.
Some of your core challenges may include:
- Limited supplier data or upstream visibility
- Risk teams siloed from supply chain functions
- Insufficient data to provide underwriters
- Inadequate contingent business interruption (CBI) insurance coverage
Get ahead of supply chain disruption and secure coverage that aligns with your life sciences organization’s risk profile with Sentrisk. Identify high-risk suppliers, stay informed with real-time alerts, and strengthen insurance submissions with more robust supplier data from Marsh’s dynamic supply chain risk management platform.
Protecting critical pharma supply chains and the patients who rely on them
Our report offers strategies you can implement to minimize supplier disruption, protect margins, and secure better coverage for your unique risk profile — based on Sentrisk’s AI-driven insights and supplier intelligence.
You’ll gain:
- A practical framework for turning enhanced visibility into faster risk prioritization
- Actionable risk mitigation strategies to better protect your supply chain
Discover how Marsh’s Sentrisk platform combines advanced data analytics and geospatial intelligence to uncover hidden supplier relationships and overlay critical risk factors such as geopolitical tensions and natural hazards.
Equipped with this comprehensive view, you can:
- Proactively identify and manage risks before they cause costly disruptions
- Make more informed business decisions
- Strengthen insurance submissions to secure better coverage